Navigation Links
2 bacterial enzymes confer resistanceto common herbicide, say MU researchers
Date:1/21/2011

COLUMBIA, Mo. In an article in the Nov. 23 issue of the journal The Proceedings of the National Academy of Science, researchers with Dow AgroSciences and the University of Missouri report on two bacterial enzymes that, when transformed into corn and soybeans, provide robust resistance to the herbicide 2,4-D. The discovery may soon provide Missouri corn and soybean growers a solution to the growing problem of herbicide-resistant weeds.

The spread of herbicide resistance has become an increasing concern for growers because undesired plants, such as Palmer amaranth and tall waterhemp in Missouri, are becoming tolerant to the broad-spectrum herbicide glyphosate, better known as Roundup.

Glyphosate is commonly used for controlling weeds in fields of Roundup Ready corn and soybean hybrids.

An herbicide commonly used to control lawn dandelions, 2,4-D, may be a new option on the horizon for growers who urgently need an alternative to glyphosate, said Zhanyuan Zhang, research associate professor of plant sciences at the University of Missouri. Zhang, director of MU's Plant Transformation Core facility, teamed up with research scientists at Dow AgroSciences, LLC, to engineer soybean plants resistant to 2,4-D.

Using a bioinformatic approach to mine a genetic database, the researchers pinpointed two bacterial enzymes - AAD-1 and AAD-12 - that break down 2,4-D. These enzymes were similar to a third bacterial enzyme that confers resistance to 2,4-D in transgenic cotton. When the new enzymes were inserted into the genome of the model plant Arabidopsis thaliana, the resulting plants showed little to no visible signs of damage when treated with 2,4-D. Plants with only the AAD-12 enzyme also survived applications of two other broadleaf herbicides, triclopyr and fluroxypr.

The herbicide protection of these enzymes was subsequently tested in corn and soybeans. Using robust transformation methods, the corn plant was engineered to produce the enzyme AAD-1, and the soybean plant engineered to produce the enzyme AAD-12.

The resulting plants were then subjected to herbicide treatment under greenhouse and field conditions at several locations and through multiple generations. Under all conditions, the plants exhibited excellent resistance to 2,4-D, even when applied at higher than normal levels. The corn plants exhibited none of the injuries commonly associated with treatment with 2,4-D, such as root malformations, and also were resistant to two grass herbicides. No negative effects on yield or other agronomic traits were observed in the transgenic corn or soybean plants.

Other advantages of 2,4-D include low cost, short environmental persistence, and low toxicity to humans and wildlife.

"Unlike glyphosate, which targets amino acid synthesis, 2,4-D is a hormone regulator. Because it has a different mode of action, 2,4-D is an ideal herbicide to deal with glyphosate-resistant weeds," said Zhang, who carried out the soybean transformation and contributed to some data analysis for the study.


'/>"/>

Contact: Melody Kroll
KrollMM@missouri.edu
573-884-4144
University of Missouri-Columbia
Source:Eurekalert

Related biology news :

1. A pesky bacterial slime reveals its survival secrets
2. Remarkable biological complexity of bacterial cells is focus of newly released book
3. TYRX AIGISRx antibacterial envelope shows low infection rate, high CIED procedure success
4. Life-saving in the bacterial world: How Campylobacter rely on Pseudomonas to infect humans
5. Insulin may reduce several inflammatory factors induced by bacterial infection
6. Antibacterial peptide could aid in treating soldiers burn wound infections
7. Management of ascites, spontaneous bacterial peritonitis, and hepatorenal syndrome in cirrhosis
8. Mining bacterial genomes reveals valuable hidden drugs
9. In the ring: Researchers fighting bacterial infections zero in on microorganisms soft spots
10. Bacterial diversity of Tablas de Daimiel studied for first time
11. New bacterial signaling molecule could lead to improved vaccines
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:12/19/2016)... TORONTO , 19 de diciembre de 2016  Mosaic ... permitirá el desarrollo acelerado de MSC-1, un anticuerpo humanizado que se ... tumor en 2017, con múltiples sitios previstos a lo largo de ... ... el factor inhibidor de leucemia (LIF), una citoquina pleiotrópica que se ...
(Date:12/16/2016)... Research and Markets has announced the addition of the ... report to their offering. ... The biometric vehicle access system market, in terms of ... 2016 to 2021. The market is estimated to be USD 442.7 ... 2021. The growth of the biometric vehicle access system market is ...
(Date:12/15/2016)... and BADEN-BADEN, Germany , December 15, 2016 ... financial services provider, today announced an agreement with NuData Security, ... to join forces. The partnership will enable clients to focus ... compliance with local data protection regulation. ... In order to provide a ...
Breaking Biology News(10 mins):
(Date:1/21/2017)...   Boston Biomedical , an industry leader in ... stemness pathways, today presented data from two clinical studies ... American Society of Clinical Oncology (ASCO) Gastrointestinal Cancers Symposium ... In a Phase Ib/II study of napabucasin – ... stemness pathways by targeting STAT3 – colorectal cancer (CRC) ...
(Date:1/20/2017)... January 20, 2017 Stock-Callers.com explores ... have influenced the most recent performances of select equities. ... RGLS ), Abeona Therapeutics Inc. (NASDAQ: ... TBPH ), and Sage Therapeutics Inc. (NASDAQ: ... Grand View Research, global Biotech market size is expected to reach $604.40 ...
(Date:1/20/2017)... -- http://www.Financialbuzz.com - According to ... of death worldwide. There were 8.2 million cancer related ... deaths increased gradually over time, the death rates have ... cancers continues to drive demand of biological therapies for ... Insights, Inc. cancer biological therapy market size was USD 61.3 ...
(Date:1/19/2017)... -- Research and Markets has announced the addition of ... Application - Global Opportunity Analysis and Industry Forecast, 2014-2022" report ... ... projected to reach $15,737 million by 2022 from $6,521 in 2015, ... Omic technologies segment accounted for more than half of ...
Breaking Biology Technology: